Clélia Coutzac

3.7k total citations · 1 hit paper
46 papers, 2.2k citations indexed

About

Clélia Coutzac is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Clélia Coutzac has authored 46 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Clélia Coutzac's work include Cancer Immunotherapy and Biomarkers (23 papers), Gastric Cancer Management and Outcomes (11 papers) and Colorectal Cancer Treatments and Studies (10 papers). Clélia Coutzac is often cited by papers focused on Cancer Immunotherapy and Biomarkers (23 papers), Gastric Cancer Management and Outcomes (11 papers) and Colorectal Cancer Treatments and Studies (10 papers). Clélia Coutzac collaborates with scholars based in France, Italy and United States. Clélia Coutzac's co-authors include Nathalie Chaput, Caroline Robert, Émilie Soularue, Franck Carbonnel, Lysiane Marthey, Michael Collins, Christine Mateus, Patricia Lepage, Émilie Lanoy and Lydie Cassard and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Hepatology.

In The Last Decade

Clélia Coutzac

37 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab

2017 972 citations Nathalie Chaput, Patricia Lepage et al. Annals of Oncology profile →

Peers

Clélia Coutzac

ONCOL

IMMUN

EPIDE

PRM

Émilie Soularue France

Daniela Damiani Italy

Lysiane Marthey France

Hamzah Abu‐Sbeih United States

Depei Wu China

Filippo Navaglia Italy

Liang Duan China

Thibaut Vaysse France

Li-Zhen Chen China

Florian Emmerich Germany

Émilie Soularue France

Clélia Coutzac

1.5k ×1.0

ONCOL

610 ×0.9

433 ×0.8

IMMUN

358 ×0.8

EPIDE

357 ×1.0

PRM

Citations per year, relative to Clélia Coutzac Clélia Coutzac (= 1×) peers Émilie Soularue

Countries citing papers authored by Clélia Coutzac

Since Specialization

Citations

This map shows the geographic impact of Clélia Coutzac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clélia Coutzac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clélia Coutzac more than expected).

Fields of papers citing papers by Clélia Coutzac

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clélia Coutzac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clélia Coutzac. The network helps show where Clélia Coutzac may publish in the future.

Co-authorship network of co-authors of Clélia Coutzac

This figure shows the co-authorship network connecting the top 25 collaborators of Clélia Coutzac. A scholar is included among the top collaborators of Clélia Coutzac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clélia Coutzac. Clélia Coutzac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dupré, Aurélien, et al.. (2024). Laparoscopic Extended Segmentectomy VIII Guided by Three-Dimensional Reconstruction and Hepatic Veins with a Cranio-Caudal Approach. Annals of Surgical Oncology. 31(10). 6567–6568. 2 indexed citations

Dupré, Aurélien, et al.. (2024). ASO Author Reflections: Minimally Invasive Surgery, Three-Dimensional (3D) Reconstruction and Indocyanine Green Fluorescence: The Perfect Combo to Enter the Era of Intraoperative Liver Navigation. Annals of Surgical Oncology. 31(10). 6580–6581. 1 indexed citations

Dupré, Aurélien, Pascal Artru, Antoine Drouillard, et al.. (2024). Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study. Digestive and Liver Disease. 56(9). 1605–1613.

Ambrosini, Margherita, David Tougeron, Dominik Paul Modest, et al.. (2024). BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancer. European Journal of Cancer. 210. 114290–114290. 7 indexed citations

Fouchardière, Christelle de la, Robert Cohen, Olivier Dubreuil, et al.. (2024). 504O IMHOTEP Phase II trial of neoadjuvant pembrolizumab in dMMR/MSI tumors: Results of the colorectal cancer cohort. Annals of Oncology. 35. S429–S429. 6 indexed citations

Tougeron, David, Simon Pernot, Thibault Mazard, et al.. (2024). 143P Efficacy of immunotherapy in gastro-intestinal (GI) tumors with mismatch repair deficient (MMRd) unusual phenotype. Annals of Oncology. 35. S272–S272. 1 indexed citations

Ducreux, Michel, Méher Ben Abdelghani, David Tougeron, et al.. (2024). 3O PRODIGE 68 - UCGI 38 - SOREGATT: A randomized phase II study comparing the sequences of regorafenib (reg) and trifluridine/tipiracil (t/t) after failure of standard therapies in patients (pts) with metastatic colorectal cancer (mCRC). Annals of Oncology. 35. S3–S3. 1 indexed citations

Cassier, Philippe A., Claire Cropet, Clélia Coutzac, et al.. (2023). 1684TiP PARPiPANC: A multicentric, single arm, phase II assessing niraparib as first line therapy for patients with metastatic homologous repair-deficient pancreatic cancer. Annals of Oncology. 34. S922–S922.

Pilla, Lorenzo, Kathrin Heinrich, Volker Kunzmann, et al.. (2023). Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: An AGEO European Cohort.. Journal of Clinical Oncology. 41(16_suppl). 4148–4148.

10.

Coutzac, Clélia, Frédéric Bigot, Damien Vansteene, et al.. (2023). 557MO Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic anal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial. Annals of Oncology. 34. S415–S415. 3 indexed citations

11.

Tourneau, Christophe Le, Sophie Cousin, Maud Toulmonde, et al.. (2023). 138P Precision medicine phase II study evaluating the efficacy of olaparib in patients with progressive solid cancers and carriers of homologous recombination repair genes alterations. Annals of Oncology. 34. S236–S236. 2 indexed citations

12.

Fouchardière, Christelle de la, Pia Gamradt, Sylvie Chabaud, et al.. (2022). A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3. Journal of Personalized Medicine. 12(4). 623–623. 2 indexed citations

13.

Hautefeuille, Vincent, Louis de Mestier, Clélia Coutzac, et al.. (2022). Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study. International Journal of Cancer. 152(9). 1894–1902. 2 indexed citations

14.

Fouchardière, Christelle de la, Lore Decoster, Emmanuelle Samalin, et al.. (2021). Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature. Cancer Treatment Reviews. 100. 102289–102289. 5 indexed citations

15.

Coutzac, Clélia, et al.. (2021). Cancer and immunotherapy: a role for microbiota composition. European Journal of Cancer. 155. 145–154. 22 indexed citations

16.

Coutzac, Clélia, Simon Pernot, Nathalie Chaput, & Aziz Zaanan. (2018). Immunotherapy in advanced gastric cancer, is it the future?. Critical Reviews in Oncology/Hematology. 133. 25–32. 98 indexed citations

17.

Soularue, Émilie, Patricia Lepage, Jean Frederic Colombel, et al.. (2018). Enterocolitis due to immune checkpoint inhibitors: a systematic review. Gut. 67(11). 2056–2067. 184 indexed citations

18.

Chaput, Nathalie, Patricia Lepage, Clélia Coutzac, et al.. (2017). Baseline gut microbiota in metastatic melanoma patients treated with ipilimumab: Relation with clinical response and colitis. Annals of Oncology. 28. v28–v29. 4 indexed citations

19.

Carbonnel, Franck, Émilie Soularue, Clélia Coutzac, et al.. (2017). Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?. Seminars in Immunopathology. 39(3). 327–331. 19 indexed citations

20.

Desbois, Mélanie, Clélia Coutzac, Elie Marcheteau, et al.. (2016). IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists. The Journal of Immunology. 197(1). 168–178. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact